Atlas Trials

RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157

Clinical trial NCT02095691 · COMPLETED

Trial details

NCT number
NCT02095691
Sponsor
Biosense Webster, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertension, Renal
Start date
2013-10-01
Primary completion
2014-03-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.